Article | March 28, 2016

Rethinking "Patient Centricity": Using Technologies To Distribute Clinical Trial Results Direct To Patient

Source: Oracle Health Sciences
clinical trials

The drug development community is increasingly turning to patient engagement or “patient centricity” approaches to optimize clinical trials costs and improve research outcomes. The active participation of patients in clinical research can potentially lead to improvements in the credibility of results, higher rates of enrollment and retention, and ultimately, lower trial costs. Sponsors have been taking the initiative to get in touch with patients to better understand and reinvent the clinical trial process. And governments are also taking action. In 2010, the US government created the Patient Outcomes Research Institute (PCORI) with a $3 billion dollar budget to support research designed to help doctors and patients make informed health care decisions. A central goal of PCORI is ensuring that patients are involved in driving decisions such as determining research priorities, reviewing grants, and providing input on issues that relate to PCORI’s mission. Joe Selby, executive director of PCORI, outlined the importance of patient engagement for his organization in a guest blog for healthcare policy journal Health Affairs: “We’ve made engagement a cornerstone of our research. Every research study we fund must include a plan to engage patients, their clinicians and others across the healthcare community to ensure the research focuses on practical questions.”